A randomized, controlled trial of antepartum thyrotropin-releasing hormone and betamethasone in the prevention of respiratory disease in preterm infants
- 1 July 1994
- journal article
- clinical trial
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 171 (1) , 11-16
- https://doi.org/10.1016/s0002-9378(94)70070-2
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Pulmonary Surfactant TherapyNew England Journal of Medicine, 1993
- Beneficial effects of the combined use of prenatal corticosteroids and postnatal surfactant on preterm infantsAmerican Journal of Obstetrics and Gynecology, 1993
- Respiratory disease in very-low-birthweight infants after prenatal thyrotropin-releasing hormone and glucocorticoidThe Lancet, 1992
- Glucocorticoid effects on rabbit fetal lung maturation in vivo: An ultrastructural morphometric studyThe Anatomical Record, 1992
- Effect of maternal administration of thyrotropin releasing hormone on the preterm fetal pituitary-thyroid axisThe Journal of Pediatrics, 1991
- Dose response of thyrotropin-releasing hormone on pulmonary maturation in corticosteroid-treated preterm rabbitsAmerican Journal of Obstetrics and Gynecology, 1990
- The effects of corticosteroid administration before preterm delivery: an overview of the evidence from controlled trialsBJOG: An International Journal of Obstetrics and Gynaecology, 1990
- Impact of antenatal dexamethasone administration on respiratory distress syndrome in surfactant-treated infantsAmerican Journal of Obstetrics and Gynecology, 1989
- Gestational Effects of Corticosteroids and Surfactant in Ventilated RabbitsPediatric Research, 1989
- Effects of Maternal Treatment with Corticosteriods, T3, TRH, and Their Combinations on Lung Function of Ventilated Preterm Rabbits with and without Surfactant TreatmentsAmerican Review of Respiratory Disease, 1987